Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q41653881
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010836.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q41653881
|
035
|
|
|
‡a
(OCoLC)Q41653881
|
100
|
0 |
|
‡a
Maïlys De Sousa Mendes
‡9
en
‡9
ast
‡9
sl
|
670
|
|
|
‡a
Author's Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study
|
670
|
|
|
‡a
Author's Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women
|
670
|
|
|
‡a
Author's Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients
|
670
|
|
|
‡a
Author's Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models
|
919
|
|
|
‡a
predictionofhumanfet Alpha rmacokineticsusingexvivohumanplacentaperfusionstudiesandphysiologicallybasedmodels
‡A
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models
‡9
1
|
919
|
|
|
‡a
emtricitabineseminalplasmaandbloodplasmapopulationpharmacokineticsinhivinfectedmenintheevaristanrsep49study
‡A
Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study
‡9
1
|
919
|
|
|
‡a
physiologicallybasedpharmacokineticmodelingofrenallyexcretedantiretroviraldrugsinpregnantwomen
‡A
Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women
‡9
1
|
919
|
|
|
‡a
populationpharmacokineticmodelingoftenofovirinthegenitaltractofmalehivinfectedpatients
‡A
Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients
‡9
1
|
996
|
|
|
‡2
PTBNP|1931667
|
996
|
|
|
‡2
PTBNP|202936
|
996
|
|
|
‡2
PTBNP|210410
|
996
|
|
|
‡2
SUDOC|190842059
|
996
|
|
|
‡2
ISNI|0000000373490592
|
996
|
|
|
‡2
ISNI|0000000068704638
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|